title: "Informed Consent Template for Research Data Use"
version: 1.1
last_updated: "2025-10-21"
author: "SDX Contributors"
---

# Informed Consent for Use of Health Data in Research

> ⚠️ **Disclaimer:** This is a template for demonstration purposes only.  
> Use in actual research requires IRB/legal review. All placeholders must be replaced with real values before implementation.

**Project/Study Title:** Example Health Data Study  
**Institution/Organization:** SDX Research Institute  
**Version Date:** 2025-10-21  
**IRB Protocol Number:** IRB-2025-12345

---

## 1. Key Information
You are being asked to allow the use of your health information for research.  
Before you decide, please read this form carefully and ask any questions you may have.  
Your participation is completely voluntary.

---

## 2. Purpose of the Research
The purpose of this research is to improve understanding of health conditions and care delivery by analyzing health-related data.  
Your data may help develop better tools, treatments, and technologies for patients in the future.

---

## 3. Procedures
If you agree:

- Researchers will use data already collected as part of your care.  
- No additional tests or visits are required.  
- Your data will be either:
  - **De-identified** under HIPAA §164.514 (no Authorization required), or  
  - **Coded, Limited Data Set, or identifiable PHI**, which requires a valid Authorization, IRB waiver, and/or Data Use Agreement (DUA).  
- Data may be shared with approved research partners or institutions under confidentiality agreements.  
- Only authorized personnel will access your information.

---

## 4. Risks and Discomforts
There are no physical risks to you.  
Although every effort will be made to protect your privacy, there is a small risk that someone could identify you from shared data.  

**Security measures include:**

- Encryption in transit and at rest  
- Role-based access with logging and auditing  
- Regular security assessments  

---

## 5. Benefits
There may be no direct benefit to you.  
However, your data may help researchers advance medical knowledge and improve patient care.

---

## 6. Confidentiality and Data Protection
- Personal identifiers (e.g., name, address) will be removed or replaced with a study code.  
- Data will be retained according to applicable institutional, IRB, or legal retention requirements.  
- After the retention period, data will be securely deleted or anonymized, and may be archived in de-identified form for research integrity.  
- International data transfers will comply with safeguards such as Standard Contractual Clauses (SCCs) and a Transfer Impact Assessment.  
  Participants may request a copy of the SCCs (subject to redactions) by contacting the Data Protection Officer.  
- All use of your information will comply with applicable privacy laws (e.g., HIPAA, GDPR).

---

## 7. Voluntary Participation
Taking part in this research is your choice.  
Refusing will not affect your medical care or your relationship with healthcare providers.

---

## 8. Withdrawal of Consent
You may withdraw your consent at any time by contacting the research team.  
Upon withdrawal:

- All feasible efforts will be made to instruct partners and collaborators to cease processing and delete your data.  
- Data already used in analyses, anonymized datasets, or publications cannot be retrieved, but further sharing will stop where feasible.

---

## 9. Future Use of Data

Please indicate your choices by checking one option for each statement:

**Use in future research (non-commercial):**  
☐ I give permission for my de-identified data to be used in future approved studies.  
☐ I do NOT give permission for my de-identified data to be used in future studies.  

**Use in commercial research (e.g., AI/ML model training):**  
☐ My data may be used for commercial research.  
☐ My data may NOT be used for commercial research.  
Participant initials: _______  

**Recontact for future studies:**  
☐ I wish to be recontacted for future research.  
☐ I do NOT wish to be recontacted.  

**Return of research results:**  
☐ I wish to receive individual research results.  
☐ I do NOT wish to receive individual research results.  

---

## 10. Contact Information
If you have questions or wish to withdraw consent, please contact:

**Principal Investigator:** Dr. Jane Smith — jane.smith@sdx.org — +1 (555) 123-4567  
**Ethics/IRB Contact:** irb@sdx.org  
**Data Controller:** SDX Research Institute, 123 Research Lane, City, Country  
**Data Protection Officer:** dpo@sdx.org  
**For GDPR complaints:** Contact your local Data Protection Authority

---

## 11. Authorization and Signatures

| Role | Name | Signature | Date |
|------|------|-----------|------|
| Participant / Patient |  |  |  |
| Parent/Guardian (if applicable) |  |  |  |
| Participant Assent (for minors, if applicable) |  |  |  |
| Researcher |  |  |  |
| Witness (optional) |  |  |  |

---

### HIPAA Authorization Fields

**Description of PHI to be used/disclosed:** ______________________  
**Who may disclose the information:** ____________________________  
**To whom disclosure will be made:** _____________________________  
**Purpose of disclosure:** _______________________________________  
**Expiration date or event:** ____________________________________  
**How to revoke authorization:** _________________________________  
**Notice of potential re-disclosure:** ____________________________  
☐ I acknowledge that treatment/payment is not conditioned on signing this authorization.  
☐ I acknowledge I have received a copy of this authorization.  

---

## 12. Jurisdiction-Specific Notices (GDPR and others)

**Legal Basis for Processing (GDPR):**  
- Art. 6(1)(a): Consent of the data subject  
- Art. 9(2)(a): Explicit consent for processing special-category (health) data  

You may withdraw your consent at any time without affecting the lawfulness of prior processing.  
Once data are anonymized, they are no longer subject to GDPR.  

**Data Subject Rights:**  
- Access, rectification, erasure, restriction, portability, and objection  
- Right to lodge a complaint with your Data Protection Authority  

---

### References
- [NIH Office of Science Policy – Informed Consent Resource (PDF)](https://osp.od.nih.gov/wp-content/uploads/Informed-Consent-Resource-for-Secondary-Research-with-Data-and-Biospecimens.pdf)  
- [NIA Informed Consent Template (Word)](https://www.nia.nih.gov/sites/default/files/2022-03/nia-informed-consent-template.docx)  
- [NIH ClinicalTrials.gov Example (PDF)](https://cdn.clinicaltrials.gov/large-docs/34/NCT05148234/ICF_001.pdf)
